Synovial immunopathology in psoriatic arthritis: cellular and molecular insights
Publication date: November 2025 Source: The Lancet Rheumatology, Volume 7, Issue 11 Author(s): Ryan Malcolm Hum, Maria Christofi, Samantha Louise […]
Publication date: November 2025 Source: The Lancet Rheumatology, Volume 7, Issue 11 Author(s): Ryan Malcolm Hum, Maria Christofi, Samantha Louise […]
Arthritis &Rheumatology, Accepted Article.
… Rheumatology.“Past studies have shown higher rates of RA among farmers and women who personally applied insecticides, especially those who
Immunol Med. 2025 Oct 21:1-7. doi: 10.1080/25785826.2025.2577518. Online ahead of print. ABSTRACT A 68-year-old Japanese woman was diagnosed with palmoplantar
Clin Teach. 2025 Dec;22(6):e70233. doi: 10.1111/tct.70233. NO ABSTRACT PMID:41117012 | DOI:10.1111/tct.70233
Zhen Ci Yan Jiu. 2025 Oct 25;50(10):1124-1132. doi: 10.13702/j.1000-0607.20240689. ABSTRACT OBJECTIVES: To observe the efficacy of heat-reinforcing acupuncture at “Zusanli”
Cureus. 2025 Sep 18;17(9):e92670. doi: 10.7759/cureus.92670. eCollection 2025 Sep. ABSTRACT Introduction Musculoskeletal disorders represent a major global burden, being the
Persistent exposure to certain insecticides and pesticides may increase the risk for rheumatoid arthritis among women, according to findings published
… rheumatology, gastroenterology and pharmacists. The event was held under the auspices of the Saudi Society of Rheumatology (SSR), the
Int J Rheum Dis. 2025 Oct;28(10):e70443. doi: 10.1111/1756-185x.70443. NO ABSTRACT PMID:41116187 | DOI:10.1111/1756-185x.70443
Genome Biol. 2025 Oct 20;26(1):358. doi: 10.1186/s13059-025-03771-8. ABSTRACT The field of single-cell biology is growing rapidly, generating large amounts of
Sci Rep. 2025 Oct 20;15(1):36474. doi: 10.1038/s41598-025-24189-z. ABSTRACT Cardiovascular diseases (CVDs) are the leading cause of death worldwide, and current
Cell Mol Immunol. 2025 Oct 20. doi: 10.1038/s41423-025-01355-x. Online ahead of print. ABSTRACT Inflammasomes, particularly NLRC4, play crucial roles in
Clin Rheumatol. 2025 Oct 20. doi: 10.1007/s10067-025-07718-z. Online ahead of print. ABSTRACT OBJECTIVES: Cardiovascular involvement is an important cause of
Nat Genet. 2025 Oct 20. doi: 10.1038/s41588-025-02344-6. Online ahead of print. ABSTRACT Identifying response expression quantitative trait loci (reQTLs) can
Blood Cancer J. 2025 Oct 20;15(1):167. doi: 10.1038/s41408-025-01380-z. NO ABSTRACT PMID:41115897 | DOI:10.1038/s41408-025-01380-z
Autoimmun Rev. 2025 Oct 18:103943. doi: 10.1016/j.autrev.2025.103943. Online ahead of print. ABSTRACT Immune checkpoint inhibitors (ICIs) have transformed the therapeutic
SGLT-2 inhibitors for the prevention of autoimmune rheumatic diseases jjcush@gmail.com Tue, 10/21/2025 – 00:31
Rheumatology. News · CPD. Specialities. Cardiology · Dermatology · Endocrinology … Rheumatology. Have a comment or a news tip? Email
About. About the limbic · Contact. Rheumatology. News · CPD. Specialities … Rheumatology. Have a comment or a news tip?
Telitacicept Effective in Systemic Lupus Erythematosus The NEJM has published a report from van Vollenhoven et al show https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
… Rheumatology. Researchers conducted a multicenter, open-label, 2-arm … Rheumatology clinical response (disease activity score 28 with C …
Biomol Biomed. 2025 Oct 20. doi: 10.17305/bb.2025.13043. Online ahead of print. ABSTRACT Assessment of insulin resistance is increasingly emphasized in
SAIL-RA: Finding ILD in Early RA Cohort study of early rheumatoid arthritis (RA) patients finds that interstitial lung https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
FDA Approves Obinutuzumab for Active Lupus Nephritis jjcush@gmail.com Mon, 10/20/2025 – 18:17
FDA has approved Genentech’s CD20-targeting antibody obinutuzumab (Gazyva) for the treatment of adult patients with lu https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Mon, 10/20/2025
(MedPage Today) — Chimeric antigen receptor (CAR) T-cell therapy for blood cancers appeared less toxic, and patients’ hospital stays were